Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
The investigational drugs E7820, indisulam and tasisulam (aryl-sulfonamides) promote the
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
[引用][C] Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
TB Faust, H Yoon, RP Nowak, KA Donovan, Z Li… - Nature Chemical …, 2019 - cir.nii.ac.jp
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15 |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML][HTML] Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
T Faust, H Yoon, RP Nowak, KA Donovan… - Nature chemical …, 2020 - ncbi.nlm.nih.gov
The investigational drugs E7820, indisulam and tasisulam (aryl-sulfonamides) promote the
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
T Faust, H Yoon, RP Nowak, KA Donovan, Z Li, Q Cai… - bioRxiv, 2019 - biorxiv.org
The investigational drugs E7820, indisulam and tasisulam (aryl-sulfonamides) promote the
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
TB Faust, H Yoon, RP Nowak… - Nature chemical …, 2020 - pubmed.ncbi.nlm.nih.gov
The investigational drugs E7820, indisulam and tasisulam (aryl-sulfonamides) promote the
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
TB Faust, H Yoon, RP Nowak, KA Donovan, Z Li… - Nature Chemical …, 2019 - osti.gov
The investigational drugs E7820, indisulam and tasisulam (aryl-sulfonamides) promote the
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.
TB Faust, H Yoon, RP Nowak, KA Donovan… - Nature Chemical …, 2019 - europepmc.org
The investigational drugs E7820, indisulam and tasisulam (aryl-sulfonamides) promote the
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
T Faust, H Yoon, RP Nowak, KA Donovan, Z Li, Q Cai… - 2019 - europepmc.org
The investigational drugs E7820, indisulam and tasisulam (aryl-sulfonamides) promote the
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …
degradation of the splicing factor RBM39 in a proteasome-dependent mechanism. While the …